Clinical Trials Browser

Hematologic Diseases × Pam2CSK4 acetate and ODN M362 combination × Clear all

NCT03097796 2023-04-27

A Multiple Ascending Dose Study of PUL-042 in Stem Cell Transplant Recipients

Phase 1 Withdrawn

Hematologic Diseases